IL-6 can reduce disease severity by supporting Schwann cell (SC) differentiation and myelin and axon repair, although it is elevated and promotes the inflammation during EAN and in GBS patients as mentioned previously [15]. Here, IL6 is linked to Guillain-Barre syndrome.